Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delivery of Oligodendrocyte Progenitor Cells for Spinal Cord Injury: Evaluation of a Novel Device (DOSED)

NCT06841770 is registered in ClinicalTrials.gov with Lineage Cell Therapeutics, Inc. as lead sponsor.

NCT NCT06841770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06841770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delivery of Oligodendrocyte Progenitor Cells for Spinal Cord Injury: Evaluation of a Novel Device (DOSED)
Lead sponsor
Lineage Cell Therapeutics, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
June 30, 2025
Completion date
June 30, 2037
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury, spinal cord injury cervical, spinal cord injury thoracic, spinal cord injury, acute, spinal cord injury, chronic